Stock V3V VITA 34 AG
Add to a list
To use this feature you must be a member
Log inSign up

News VITA 34 AG Börse Stuttgart

Equities

V3V

DE000A0BL849

Delayed Börse Stuttgart
Other stock markets
 11:45:05 2024-07-04 EDT 		5-day change 1st Jan Change
4.42 EUR 0.00% Intraday chart for VITA 34 AG +2.31% -15.00%
06-01 VITA 34 AG Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-30 VITA 34 AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
VITA 34 AG Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQ
Vita 34 returns to growth path in 2023
EQ
VITA 34 AG Reports Earnings Results for the Full Year Ended December 31, 2023
CI
VITA 34 : Declaration of Conformity 2024
PU
AFR: Vita 34 AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQ
Vita 34 publishes preliminary figures on the course of business in 2023
EQ
Vita 34 downsizes Management Board until further notice
EQ
DD: Vita 34 AG: AOC Health GmbH, Acquisition of shares as part of a capital increase
EQ
DD: Vita 34 AG: Jakub Julian Baran, buy
EQ
NVR: Vita 34 AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors
EQ
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development
EQ
VITA 34 AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
AFR: Vita 34 AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQ
Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements
EQ
Vita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor
EQ
VITA 34 AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. V3V Stock
  4. V3V Stock
  5. News VITA 34 AG